Using biomarkers in clinical practice in airway disease: asthma and COPD
Aims : To assess the roles of biomarkers in airway diseases (COPD and asthma), especially biomarkers in induced sputum and blood eosinophils, exhaled nitric oxide and airway hyper-responsiveness; to determine the relationships of biomarkers with risk stratification and identification of responders to treatment; and to determine the associations of biomarkers with clinical phenotypes, disease monitoring and the development of new drugs.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Paediatrician, Respiratory critical care physician, Journalist
Epidemiology, General respiratory patient care, Pulmonary function testing